A blood test can accurately predict whether someone without a known risk of preeclampsia is likely to develop the potentially ...

ArtBlood, a biotechnology company specializing in transfusion blood production, announced that it has signed a Memorandum of Understanding (MOU) with Expression Manufacturing LLC ("Expression"), the ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Shihabeddin et al utilized single-cell RNA-Seq analysis of adult P23H zebrafish animals to identify transcription factors (e2fs, Prdm1a, Sp1) expressed selectively in neural progenitors and immature ...

Northwestern Medicine investigators have discovered previously unknown metabolic changes that may contribute to the ...

Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease affecting the frontal and temporal lobes that ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world's largest contract development and manufacturing organizations ...

A decade-long study found that obesity was associated with a significantly increased risk for biologic treatment failure in ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

ORNL scientists introduce a biosensor for real-time RNA monitoring in plants, promising advancements in agriculture and ...